Vir Biotechnology (VIR) Shares Outstanding (Diluted) (2019 - 2026)

Vir Biotechnology (VIR) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Vir Biotechnology 1.56 Bn 1.56 Bn 238.95 Mn 168.88 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 168.88 Mn
Mar 31, 2026 147.36 Mn
Dec 31, 2025 138.52 Mn
Sep 30, 2025 138.93 Mn
Jun 30, 2025 138.45 Mn
Mar 31, 2025 137.47 Mn
Dec 31, 2024 136.25 Mn
Sep 30, 2024 136.65 Mn
Jun 30, 2024 136.23 Mn
Mar 31, 2024 135.28 Mn
Dec 31, 2023 134.13 Mn
Sep 30, 2023 134.29 Mn
Jun 30, 2023 134.06 Mn
Mar 31, 2023 133.55 Mn
Dec 31, 2022 134.81 Mn
Sep 30, 2022 134.96 Mn
Jun 30, 2022 132.45 Mn
Mar 31, 2022 134.54 Mn
Dec 31, 2021 133.44 Mn
Sep 30, 2021 133.85 Mn